Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Santos-Oliveira

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Journal of AOAC International|December 15, 2010
Comparison of Limulus amebocyte lysates with the United States pharmacopeial pyrogen test and the portable test system for radiopharmaceuticalsRalph Santos-Oliveira
The Tohoku Journal of Experimental Medicine|April 7, 2009
Undesirable events with radiopharmaceuticalsRalph Santos-Oliveira
Anti-Cancer Agents in Medicinal Chemistry|August 18, 2017
EDITORIAL: Radiopharmaceuticals for Cancer Therapy and DiagnosisRalph Santos-Oliveira
Revista De Salud Publica (Bogota, Colombia)|December 2, 2008
Radiopharmaceutical drug interactionsRalph Santos-Oliveira
Current Radiopharmaceuticals|December 24, 2011
Nanoradiopharmaceuticals: is that the future for nuclear medicine?Ralph Santos-Oliveira
The American Journal of the Medical Sciences|June 7, 2011
Pitfalls with radiopharmaceuticalsRalph Santos-Oliveira, Márcio Machado
Journal of Nanoscience and Nanotechnology|July 19, 2016
Nanoparticles with Therapeutic Properties Generate Various Response of Human Peripheral Blood Mononuclear CellsMarzena Szwed, Ralph Santos-Oliveira
Biomedical Microdevices|October 31, 2018
Dose calculation of radioactive nanoparticles: first considerations for the Design of Theranostic AgentsRalph Santos-Oliveira, Michael G Stabin
Diseases (Basel, Switzerland)|January 12, 2018
PPoma Review: Epidemiology, Aetiopathogenesis, Prognosis and TreatmentThais Ligiero Braga, Ralph Santos-Oliveira
Journal of Nuclear Medicine Technology|July 29, 2011
Radiopharmaceutical research and production in Brazil: a 30-year history of participation in the nuclear medicine scenarioRalph Santos-Oliveira, Leila Jorge Antunes
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Journal of AOAC International|December 15, 2010
Comparison of Limulus amebocyte lysates with the United States pharmacopeial pyrogen test and the portable test system for radiopharmaceuticalsRalph Santos-Oliveira
The Tohoku Journal of Experimental Medicine|April 7, 2009
Undesirable events with radiopharmaceuticalsRalph Santos-Oliveira
Anti-Cancer Agents in Medicinal Chemistry|August 18, 2017
EDITORIAL: Radiopharmaceuticals for Cancer Therapy and DiagnosisRalph Santos-Oliveira
Revista De Salud Publica (Bogota, Colombia)|December 2, 2008
Radiopharmaceutical drug interactionsRalph Santos-Oliveira
Current Radiopharmaceuticals|December 24, 2011
Nanoradiopharmaceuticals: is that the future for nuclear medicine?Ralph Santos-Oliveira
The American Journal of the Medical Sciences|June 7, 2011
Pitfalls with radiopharmaceuticalsRalph Santos-Oliveira, Márcio Machado
Journal of Nanoscience and Nanotechnology|July 19, 2016
Nanoparticles with Therapeutic Properties Generate Various Response of Human Peripheral Blood Mononuclear CellsMarzena Szwed, Ralph Santos-Oliveira
Biomedical Microdevices|October 31, 2018
Dose calculation of radioactive nanoparticles: first considerations for the Design of Theranostic AgentsRalph Santos-Oliveira, Michael G Stabin
Diseases (Basel, Switzerland)|January 12, 2018
PPoma Review: Epidemiology, Aetiopathogenesis, Prognosis and TreatmentThais Ligiero Braga, Ralph Santos-Oliveira
Journal of Nuclear Medicine Technology|July 29, 2011
Radiopharmaceutical research and production in Brazil: a 30-year history of participation in the nuclear medicine scenarioRalph Santos-Oliveira, Leila Jorge Antunes
Pageof 18